Leptin contributes to the protection of human leukemic cells from cisplatinum cytoxicity.

Efferth, T; Fabry, U; Osieka, R

Efferth, T; Fabry, U; Osieka, R.

Affiliation

Efferth T; Hospital for Internal Medicine IV, RWTH Aachen, Germany. tseffert@viro.med.uni-erlangen.de

Anticancer Res ; 20(4): 2541-6, 2000.

Article in En | MEDLINE | ID: mdl-10953324

Subject(s)

Antineoplastic Agents/pharmacology; Cisplatin/pharmacology; K562 Cells/drug effects; Leptin/physiology; Cell Survival/drug effects; DNA Damage/drug effects; DNA Repair/drug effects; DNA-Binding Proteins/physiology; Dose-Response Relationship, Drug; Humans; Oligonucleotides, Antisense/pharmacology; Polymerase Chain Reaction; STAT3 Transcription Factor; Trans-Activators/physiology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Cisplatin / K562 Cells / Leptin / Antineoplastic Agents Limits: Humans Language: En Journal: Anticancer Res Year: 2000 Document type: Article

Search on Google

XML

PubMed Links